These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8955227)

  • 1. The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution.
    Tincani A; Spatola L; Prati E; Allegri F; Ferremi P; Cattaneo R; Meroni P; Balestrieri G
    J Immunol; 1996 Dec; 157(12):5732-8. PubMed ID: 8955227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
    Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of B cell epitopes on beta2-glycoprotein I.
    Cockerill KA; Linnik MD; Iverson GM
    Clin Immunol; 2004 Aug; 112(2):129-35. PubMed ID: 15240155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
    Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
    J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries.
    Zager U; Kveder T; Cučnik S; Božič B; Lunder M
    Autoimmunity; 2014 Nov; 47(7):438-44. PubMed ID: 24819195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.
    George J; Gilburd B; Hojnik M; Levy Y; Langevitz P; Matsuura E; Koike T; Shoenfeld Y
    J Immunol; 1998 Apr; 160(8):3917-23. PubMed ID: 9558098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
    Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
    J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.
    Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y
    Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
    Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
    Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule.
    Tincani A; Gilburd B; Abu-Shakra M; Blank M; Allegri F; Ottaviani R; Riboni M; Meroni PL; Balestrieri G; Shoenfeld Y
    Arthritis Rheum; 2002 May; 46(5):1399-404. PubMed ID: 12115248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection.
    Blank M; Shani A; Goldberg I; Kopolovic J; Amigo MC; Magrini L; Shoenfeld Y
    Thromb Res; 2004; 114(5-6):589-92. PubMed ID: 15507295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.